Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SIGNATURE Study: Post-market, Randomized Controlled, Multicenter, Single Blinded Prospective Trial Investigating the Paclitaxel-Coated Balloon (Legflow DCB) Treatment Versus Uncoated Balloon Angioplasty Treatment for Femoro-popliteal Lesions.

NCT04971772 is registered in ClinicalTrials.gov with Cardionovum GmbH as lead sponsor.

NCT NCT04971772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04971772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SIGNATURE Study: Post-market, Randomized Controlled, Multicenter, Single Blinded Prospective Trial Investigating the Paclitaxel-Coated Balloon (Legflow DCB) Treatment Versus Uncoated Balloon Angioplasty Treatment for Femoro-popliteal Lesions.
Lead sponsor
Cardionovum GmbH
Phase
Observational
Overall status
Active, not recruiting
Start date
June 8, 2022
Completion date
January 31, 2028
Enrollment
150 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

angiopathy, peripheral, peripheral arterial disease, superficial femoral artery stenosis